Fundraising FoxInCube Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Rani Therapeutics is a clinical-stage biopharmaceutical company developing oral delivery technologies for biologics and drugs, primarily through its proprietary RaniPill capsule platform, which comes in two configurations (RaniPill GO for up to 3 mg microtablet doses and RaniPill HC for up to 200µL liquid doses).
BiotechSan Jose, US
Talat Imran(Executive Officer, Director)inSvai Sanford(Executive Officer)inMir Hashim(Executive Officer)in
BoardAbraham Bassan(Director)Vasudev Bailey, M.D.(Director)
Board seatMir Imran· per SEC Form D · $60.3M raise · filed Nov 2025
Co-investorsRA Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.